Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-22356
Structure of SARS-CoV-2 3Q full-length prefusion trimer
EMD-22356
Single-particle4.0 Å
Deposition: 26/07/2020Map released: 26/08/2020
Last modified: 23/12/2020
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 full-length spike
Deposition Authors: Bangaru S, Turner HL, Ozorowski G, Antanasijevic A, Ward AB
Sample: SARS-CoV-2 full-length spike
Deposition Authors: Bangaru S, Turner HL, Ozorowski G, Antanasijevic A, Ward AB
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
Bangaru S
,
Ozorowski G
,
Turner HL,
Antanasijevic A
,
Huang D
,
Wang X
,
Torres JL
,
Diedrich JK
,
Tian JH,
Portnoff AD,
Patel N,
Massare MJ,
Nemazee D
,
Paulson JC
,
Glenn G
,
Smith G,
Ward AB
(2020) Science , 370 , 1089 - 1094
,
Ozorowski G
,
Turner HL,
Antanasijevic A
,
Huang D
,
Wang X
,
Torres JL
,
Diedrich JK
,
Tian JH,
Portnoff AD,
Patel N,
Massare MJ,
Nemazee D
,
Paulson JC
,
Glenn G
,
Smith G,
Ward AB
(2020) Science , 370 , 1089 - 1094
Grant Support:
- Bill & Melinda Gates Foundation: OPP1170236 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): UM1 AI144462 (United States)
